Skip to main content

Advertisement

Table 2 Societal data for patients with a positive evolution of their ETDRS score over 24 months of follow-up (21.8% of patients): for positive ETDRS score evolution (first line): 3 corresponds to changes between 0 and + 5 letters; 4 corresponds to changes between + 5 and + 10 letters

From: Influence of new societal factors on neovascular age-related macular degeneration outcomes

Variable Categories Percentage
Positive ETDRS Score evolution 3 70.588
  4 29.412
Number of injections between baseline and M24 0 5.882
  2 5.882
  5 17.647
  6 29.412
  8 5.882
  9 5.882
  10 5.882
  14 11.765
  15 5.882
  17 5.882
Outpatient follow-up No 88.235
  Yes 5.882
  Sometimes 5.882
Family status Couple 41.176
  Living alone 52.941
  Family 5.882
Transportation to the clinic Medicalized vehicle 52.941
  Taxi 23.529
  Public transportation 5.882
  Personal car 17.647
Commuting time to the clinic 0 to 1 h 47.059
  1 to 2 h 47.059
  More than 2 h 5.882
Low vision rehabilitation No 94.118
  Yes 5.882
Daily reading None 11.765
  Journal 58.824
  Books 23.529
  Computer 5.882
Health assurance covering 100% of expenses No 29.412
  Yes 70.588
Economic burden of the treatment on the patient (0–10 scale) 2 5.882
  3 17.647
  4 29.412
  5 17.647
  6 17.647
  7 5.882
  8 5.882
Painfulness of the treatment burden (0–10 scale) 2 17.647
  3 11.765
  4 23.529
  5 17.647
  6 5.882
  7 17.647
  8 5.882